ProQR CEO Daniel Anton de Boer acquires 200,000 shares for $353,960
PRQR•CEO buys 200,000 ordinary shares
ProQR Therapeutics CEO Daniel Anton de Boer bought 200,000 ordinary shares at $1.77 each, lifting direct holdings to 500,000 shares.
PRQR•ProQR Therapeutics CEO Daniel Anton de Boer bought 200,000 ordinary shares at $1.77 each, lifting direct holdings to 500,000 shares.